Biliary excretion of amphotericin B deoxycholate and amphotericin B lipid complex [4]

Scandinavian Journal of Infectious Diseases

Volumn 32, Issue 5, 2000, Pages 581-

  Dulfo, F ^a   Allaouchiche, B ^a   Chassard, D ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX;

AGED; ANTIBIOTIC RESISTANCE; BILIARY EXCRETION; BILIARY TRACT DRAINAGE; BILIARY TRACT SURGERY; CANCER; CANDIDA GLABRATA; CASE REPORT; CRITICAL ILLNESS; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EXCRETION; DRUG INDICATION; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; FEMALE; FUNGICIDAL ACTIVITY; HUMAN; KIDNEY FAILURE; LETTER; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MYCOSIS; NEPHROTOXICITY; SIDE EFFECT;

EID: 0033790935     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655400459009     Document Type: Letter

References (4)

1. In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections
2. Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B deoxycholate
3. Systematically administered antifungal agents
4. Quantitative extraction of amphotericin B from serum and its determination by high-pressure liquid chromatography